80 related articles for article (PubMed ID: 38439082)
1. Extrachromosomal circular DNA in cancer: history, current knowledge, and methods.
Noer JB; Hørsdal OK; Xiang X; Luo Y; Regenberg B
Trends Genet; 2022 Jul; 38(7):766-781. PubMed ID: 35277298
[TBL] [Abstract][Full Text] [Related]
2. Overcoming proteasome inhibitor resistance in the immunotherapy era.
Patiño-Escobar B; Talbot A; Wiita AP
Trends Pharmacol Sci; 2023 Aug; 44(8):507-518. PubMed ID: 37344251
[TBL] [Abstract][Full Text] [Related]
3. MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis.
Wang X; Shi Y; Shi H; Liu X; Liao A; Liu Z; Orlowski RZ; Zhang R; Wang H
J Exp Clin Cancer Res; 2024 Mar; 43(1):68. PubMed ID: 38439082
[TBL] [Abstract][Full Text] [Related]
4. Mucin 20 modulates proteasome capacity through c-Met signalling to increase carfilzomib sensitivity in mantle cell lymphoma.
Wang X; Shirazi F; Yan W; Liu X; Wang H; Orlowski RZ; Wang H
J Cell Mol Med; 2021 Nov; 25(21):10164-10174. PubMed ID: 34651428
[TBL] [Abstract][Full Text] [Related]
5. Novel cell line models to study mechanisms and overcoming strategies of proteasome inhibitor resistance in multiple myeloma.
Brünnert D; Kraus M; Stühmer T; Kirner S; Heiden R; Goyal P; Driessen C; Bargou RC; Chatterjee M
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1666-1676. PubMed ID: 30954557
[TBL] [Abstract][Full Text] [Related]
6. Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance.
Ge M; Qiao Z; Kong Y; Liang H; Sun Y; Lu H; Xu Z; Liu H
Br J Cancer; 2021 Feb; 124(4):770-776. PubMed ID: 33250513
[TBL] [Abstract][Full Text] [Related]
7. MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.
Qiang YW; Ye S; Chen Y; Buros AF; Edmonson R; van Rhee F; Barlogie B; Epstein J; Morgan GJ; Davies FE
Blood; 2016 Dec; 128(25):2919-2930. PubMed ID: 27793878
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors.
Prelowska MK; Mehlich D; Ugurlu MT; Kedzierska H; Cwiek A; Kosnik A; Kaminska K; Marusiak AA; Nowis D
Cancer Lett; 2021 Jun; 507():13-25. PubMed ID: 33713737
[TBL] [Abstract][Full Text] [Related]
9. RNA binding motif protein 45-mediated phosphorylation enhances protein stability of ASCT2 to promote hepatocellular carcinoma progression.
Du D; Qin M; Shi L; Liu C; Jiang J; Liao Z; Wang H; Zhang Z; Sun L; Fan H; Liu Z; Yu H; Li H; Peng J; Yuan S; Yang M; Xiong J
Oncogene; 2023 Oct; 42(42):3127-3141. PubMed ID: 37658192
[TBL] [Abstract][Full Text] [Related]
10. Identification and study of cuproptosis-related genes in prognostic model of multiple myeloma.
Wang H; Zhang G; Dong L; Chen L; Liang L; Ge L; Gai D; Shen X
Hematology; 2023 Dec; 28(1):2249217. PubMed ID: 37610069
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer.
Wen H; Qu C; Wang Z; Gao H; Liu W; Wang H; Sun H; Gu J; Yang Z; Wang X
FASEB J; 2023 Sep; 37(9):e23145. PubMed ID: 37584654
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics.
Xu B; Yang K; Han X; Hou J
Inflamm Res; 2023 Jun; 72(6):1147-1160. PubMed ID: 37166466
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma.
Zhang B; Wang Q; Zhang T; Zheng Z; Lin Z; Zhou S; Zheng D; Chen Z; Zheng S; Zhang Y; Lin X; Dong R; Chen J; Qian H; Hu X; Zhuang Y; Zhang Q; Jin Z; Jiang S; Ma Y
Front Cell Dev Biol; 2023; 11():1159355. PubMed ID: 37152283
[No Abstract] [Full Text] [Related]
14. METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.
Zhang L; Wang X; Che W; Zhou S; Feng Y
Brain Res; 2023 Jul; 1811():148373. PubMed ID: 37105375
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of prognosis of cuproptosis-related oxidative stress genes in multiple myeloma.
Li T; Yao L; Hua Y; Wu Q
Front Genet; 2023; 14():1100170. PubMed ID: 37065484
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
